Translational medicine has been synonymous with Mount Sinai since the founding of The Hospital in the mid-19th century, when our doctors turned to their microscopes to better understand the conditions they encountered in their patients. This passion for patient-focused research lies at the heart of our 14 new translational research institutes-- each designed to facilitate breakthrough science in the most urgent and promising areas of medical science.
The Black Family Stem Cell Institute
Brain Institute
Charles R. Bronfman Institute for Personalized Medicine
Child Health and Development Institute
Disease Prevention and Public Health Institute
Experimental Therapeutics Institute
Immunology Institute
Global Health and Emerging Pathogens Institute
Metabolism Institute
Mount Sinai Heart
The Tisch Cancer Institute
Translational and Molecular Imaging Institute
“The creation of these 14 health- and disease-related institutes is the cornerstone of our strategy for becoming a world leader in science and medicine. By breaking down conventional boundaries between departments and disciplines, we will maximize the potential of our outstanding faculty to make breakthrough discoveries that will change the face of modern medicine.”
Dennis S. Charney, MD
Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine; Executive Vice President for Academic Affairs, The Mount Sinai Medical Center; Professor of Psychiatry, Neuroscience, and Pharmacology and Systems Therapeutics